The role of antibiotics in chronic bacterial prostatitis

International Journal of Antimicrobial Agents

Volumn 26, Issue 1, 2005, Pages 1-7

  Wagenlehner, F M E ^a,b   Weidner, W ^b   Sorgel F ^c,d   Naber, K G ^a  

^a Urologische Klinik   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c Institute for Biomedical and Pharmaceutical Research (IBMP)   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Fluoroquinolones; NIH classification; Prostatic fluid (secretion); Prostatic tissue; Prostatitis; Seminal fluid (secretion)

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; CIPROFLOXACIN; ENOXACIN; FLEROXACIN; GATIFLOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; MACROLIDE; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; SPARFLOXACIN;

ANTIBIOTIC THERAPY; CLINICAL TRIAL; DRUG PENETRATION; DRUG TRANSPORT; HUMAN; NONHUMAN; PELVIS PAIN SYNDROME; PH; PRIORITY JOURNAL; PROSTATE SECRETION; PROSTATITIS; RECURRENT DISEASE; REVIEW; SEMINAL PLASMA; URINE CULTURE; VOLUNTEER;

EID: 20744435505     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.04.013     Document Type: Short Survey

References (56)

1. A.J. Schaeffer Prostatitis: US perspective Int J Antimicrob Agents 11 1999 205 211
2. Workshop Committee of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Chronic Prostatitis Workshop; Bethesda, MD, USA; 7-8 Dec. 1995.
3. K.G. Naber, B. Bergman, M.C. Bishop and European Association of Urology (EAU) EAU guidelines on urinary and male genital tract infections 2001 European Association of Urology Njimegen, The Netherlands p. 1-75
4. E.M. Meares, and T.A. Stamey Bacteriologic localization patterns in bacterial prostatitis and urethris Invest Urol 5 1968 492 518
5. J.N. Krieger, R.E. Berger, S.O. Ross, I. Rothman, and C.H. Muller Seminal fluid findings in men with nonbacterial prostatitis and prostatodynia J Androl 17 1996 310 318
6. W. Weidner, C. Jantos, H.G. Schiefer, G. Haidl, and H.J. Friedrich Semen parameters in men with and without proven chronic prostatitis Arch Androl 26 1991 173 183
7. W. Weidner, H.G. Schiefer, H. Krauss, Ch. Jantos, H.J. Friedrich, and M. Altmannsberger Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1461 patients Infection 19 Suppl. 3 1991 119 125
8. K.G. Naber, and W. Weidner Prostatitis, epididymitis and orchitis D. Armstrong J. Cohen Infectious diseases 1999 Mosby London, UK 1 58
9. J.C. Nickel, M.E. Olson, and J.W. Costerton Rat model of experimental bacterial prostatitis Infection 19 1991 126 130
10. T.A. Stamey, E.M. Meares, and G. Winningham Chronic bacterial prostatitis and the diffusion of drugs into the prostatic fluid J Urol 103 1970 187 194
11. P.O. Madsen, and P.R. Whalen Interaction between antimicrobial agents and prostatic tissue extract and fluid Infection 6 1978 75 77
12. T.A. Stamey, S.R.M. Bushby, and J. Bragonje The concentration of trimethoprim in prostatic fluid: non-ionic diffusion or active transport? J Infect Dis 129 Suppl. 1973 686 690
13. P.O. Madsen, T.B. Kjaer, and A. Baumeller Prostatic tissue and fluid concentrations of trimethoprim and sulfamethoxazole. Experimental and clinical studies Urology 8 1976 129 132
14. T.C. Gasser, E.H. Larsen, T. Dorflinger, and P.O. Madsen The influence of various body fluids and pH on E. coli MIC of quinolone derivatives W. Weidner Therapy of prostatitis. Experimental and clinical data 1986 Zuckschwerdt Munich, Germany 50 53
15. F. Sörgel, J. Bulitta, and M. Kinzig-Schippers Pharmakokinetik der Chinolone Chemother J 11 Suppl. 20 2002 25 33
16. K.G. Naber, M. Kinzig, F. Sörgel, and D. Weigel Penetration of ofloxacin into prostatic fluid, ejaculate and seminal fluid Infection 21 1993 34 39
17. K.G. Naber, F. Sörgel, M. Kinzig, and D.M. Weigel Penetration of ciprofloxacin into prostatic fluid, ejaculate and seminal fluid in volunteers after an oral dose of 750 mg J Urol 150 1993 1718 1721
18. K.G. Naber Role of quinolones in treatment of chronic bacterial prostatitis D.C. Hooper J.S. Wofson Quinolone antimicrobial agents 2nd ed. 1993 American Society of Microbiology Washington, DC 285 297
19. C.K. Naber, M. Steghafner, and M. Kinzig-Schippers Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administration of 400 milligrams to volunteers Antimicrob Agents Chemother 45 2001 293 297
20. F. Sörgel, M. Kinzig-Schippers, and K.G. Naber Physiological disposition of macrolides A.J. Bryskier J.-P. Butzler H.C. Neu P.M. Tulkens Macrolides. Chemistry, pharmacology and clinical uses 1993 Arnette Blackwell Paris, France 421 431
21. EM. Meares Jr Prostatitis. A review Urol Clin North Am 2 1975 3 27
22. W.R. Fair, and J.J. Cordonnier The pH of prostatic fluid: a reappraisal and therapeutic implication J Urol 120 1978 695 698
23. R.U. Anderson, and W.R. Fair Physical and chemical determinations of prostatic secretion in benign hyperplasia, prostatitis and adenocarcinoma Invest Urol 14 1976 137 140
24. N.J. Blacklock, and J.P. Beavis The response of fluid pH in inflammation Br J Urol 46 1978 537 542
25. A. Pfau, S. Perlberg, and A. Shapiro The pH of the prostatic fluid in health and disease: implications of treatment in chronic bacterial prostatitis J Urol 119 1978 384 387
26. K.G. Naber, D. Adam, and F. Kees In vitro activity and concentrations in serum, urine, prostatic secretion and adenoma tissue of ofloxacin in urological patients Drugs 34 Suppl. 1 1987 44 50
27. Naber KG, Sörgel F, Kees F, Schumacher H, Metz R, Grobecker H, Norfloxacin concentration in prostatic adenoma tissue (patients) and in prostatic fluid in patients and volunteers. In: Proceedings of the 15th International Congress of Chemotherapy; Landsberg, Germany. Ecomed 1987;1956-8.
28. K.G. Naber, F. Sörgel, and F. Kees In vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and prostatic fluid and in prostatic adenoma tissue J Antimicrob Chemother 21 Suppl. D 1988 199 207
29. K.G. Naber, F. Sörgel, F. Kees, U. Jaehde, and H. Schumacher Pharmakokinetik von Ciprofloxacin bei Probanden und älteren Patienten und Konzentrationen im Prostatasekret, Ejakulat und im Prostataadenomgewebe nach intravenöser Gabe D. Adam A. Dalhoff B. Wiedemann Fortschritte Antimicrobieller Antineoplastischer Chemotherapie FAC 8-1 1989 Futuramed Munich, Germany 75 87
30. K.G. Naber, F. Sörgel, F. Kees, U. Jaehde, and H. Schumacher Brief report: pharmacokinetics of ciprofloxacin in young (healthy) volunteers and elderly patients, and concentrations in prostatic fluid, seminal fluid and prostatic adenoma tissue following intravenous administration Am J Med 87 Suppl. 5A 1989 57 59
31. K.G. Naber, F. Sörgel, and F. Kees Enoxacin-Konzentrationen in der Samenflüssigkeit, im Prostatasekret und im Prostatadenomgewebe nach oraler Gabe oder intravenöser Infusion Infection 17 Suppl. 1 1989 30 36
32. Naber KG, Sörgel F, Sigl G, Schumacher H, Metz R. Lomefloxacin: penetration into prostatic and seminal fluid in volunteers. In: Proceedings of the 3rd International Symposium on new quinoles. 1990 [Abstract 248].
33. K.G. Naber, and P.O. Madsen Antibiotics: basic concepts J.C. Nickel Textbook of prostatitis 1999 Isis Medical Media Oxford, UK 83 94
34. Bulitta J, Kinzig-Schippers M, Naber CK, et al. Limitations in the use of drug cocktails (DC) to compare the pharmacokinetics (PK) of drugs: ciprofloxacin (CIP) vs. levofloxacin (LEV). Proceedings of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); Toronto, Canada; 17-20 Sept 2000 [Poster #506].
35. J.C.D. Png, E. Tan, K.T. Foo, M.K. Li, C. Cheng, and I.R. Rekhraj A comparative study of the distribution of ofloxacin and ciprofloxacin in prostatic tissue after simultaneous oral ingestion Br J Urol 79 1997 781 784
36. H. Park, T. Lee, J. Lee, S. Chang, and Woo Y Simultaneous determination of levofloxacin and ciprofloxacin concentrations in serum and prostatic tissue Proceedings of the 20th International Congress of Chemotherapy Sydney 1997 [Abstract 3291]
37. K.G. Naber, and H. Giamarellou Proposed study design in prostatitis Infection 22 Suppl. 1 1994 59 60
38. A.J. Schaeffer, and F.S. Darras The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim- sulfamethoxazole and/or carbenicillin J Urol 144 1990 690 693
39. Petrikkos G, Peppas T, Giamarellou H, Poulios K, Zouboulis P, Sfikakis P. Four year experience with norfloxacin in the treatment of chronic bacterial prostatitis. In: Proceedings of the 17th International Congress of Chemotherapy; 1991 [Abstract 1302].
40. R.A. Pust, H.R. Ackenheil-Koppe, P. Gilbert, and W. Weidner Clinical efficacy of ofloxacin (Tarivid) in patients with chronic bacterial prostatitis: preliminary results J Chemother 1 Suppl. 4A 1989 469 471
41. W. Weidner, H.G. Schiefer, and A. Dalhoff Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one-year follow-up study Am J Med 82 Suppl. 4A 1987 280 283
42. W. Weidner, H.G. Schiefer, and E. Brähler Refractory chronic bacterial prostatitis: a re-evaluation of ciprofloxacin treatment after a median follow-up of 30 months J Urol 146 1991 350 352
43. A. Pfau Therapie der unteren Harnwegsinfektionen beim Mann unter besonderer Berücksichtigung der chronischen bakteriellen Prostatitis Akt Urol 18 1987 31 33
44. A. Pfau The treatment of chronic bacterial prostatitis Infection 19 Suppl. 3 1991 160 164
45. K.G. Naber, W. Busch, J. Focht the German Prostatitis Study Group Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up Int J Antimicrob Agents 14 2000 143 149
46. K.G. Naber the European Lomefloxacin Prostatitis Study Group Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis Int J Antimicrob Agents 20 2002 18 27
47. M.S. Litwin, M. McNaughton-Collins, and F.J. Fowler Jr National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of new outcome measure J Urol 162 1999 369 375
48. W. Bundrick, S.P. Heron, and P. Ray Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study Urology 62 2003 537 541
49. Naber KG Antibiotic treatment of chronic bacterial prostatitis J.C. Nickel Textbook of prostatitis 1999 Isis Medical Media Oxford, UK 285 292
50. T.E. Bjerklund Johansen, R.N. Grüneberg, and J. Guibert The role of antibiotics in the treatment of chronic prostatitis: a consensus statement Eur Urol 34 1998 457 466
51. J.S. Mayersak Transurethral ultrasonography directed intraprostatic injection of gentamycin-xylocaine in the management of the benign painful prostate syndrome. A report of a 5 year clinical study of 75 patients Int Surg 83 1998 347 349
52. J.F. Jimenez Cruz, F. Boronat, and J. Gallego Treatment of chronic prostatitis: intraprostatic injection under echography control J Urol 139 1988 967 970
53. J.N. Krieger, D.E. Riley, R.L. Vesella, D.C. Miner, S.O. Ross, and P.H. Lange Bacterial DNA sequences in prostate tissue from patients with prostate cancer and chronic prostatitis J Urol 164 2000 1221 1228
54. J.J.M.C. De la Rosette, M.R. Hubregste, E.J.H. Meuleman, M.V.M. Stolk-Engelaar, and F.M.J. Debruyne Diagnosis and treatment of 409 patients with prostatitis syndromes Urology 41 1993 301 307
55. M. Ohkawa, K. Yamaguchi, S. Tokunaga, T. Nakashima, and R. Shoda Antimicrobial treatment for chronic prostatitis as a means of defining the role of Ureaplasma urealyticum Urol Int 51 1993 129 132
56. P.O. Madsen, T.B. Kjaer, and A. Baumueller Prostatic tissue and fluid concentration of trimethoprim and sulfamethoxazole Urology 8 1976 129 132